{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:12:54Z","timestamp":1793412774878,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s40272-023-00596-5","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T13:01:41Z","timestamp":1696424501000},"page":"31-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2729-9658","authenticated-orcid":false,"given":"Ai Tien","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kon\u00e9-Paut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Dusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"596_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/ICU.0000000000000501","volume":"29","author":"KC LaMattina","year":"2018","unstructured":"LaMattina KC, Koreishi AF. What is new in paediatric uveitis? Curr Opin Ophthalmol. 2018;29:412.","journal-title":"Curr Opin Ophthalmol"},{"key":"596_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0002-9394(03)00314-3","volume":"135","author":"GN Holland","year":"2003","unstructured":"Holland GN, Stiehm ER. Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol. 2003;135:867\u201378.","journal-title":"Am J Ophthalmol"},{"key":"596_CR3","doi-asserted-by":"crossref","first-page":"251584142096645","DOI":"10.1177\/2515841420966451","volume":"12","author":"N Rahman","year":"2020","unstructured":"Rahman N, Petrushkin H, Solebo AL. Paediatric autoimmune and autoinflammatory conditions associated with uveitis. Ther Adv Ophthalmol. 2020;12:2515841420966451.","journal-title":"Ther Adv Ophthalmol"},{"key":"596_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0002-9394(02)02148-7","volume":"135","author":"C Edelsten","year":"2003","unstructured":"Edelsten C, Reddy MA, Stanford MR, Graham EM. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135:676\u201380.","journal-title":"Am J Ophthalmol"},{"key":"596_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.2147\/OPTH.S83950","volume":"9","author":"SB Engelhard","year":"2015","unstructured":"Engelhard SB, Bajwa A, Reddy AK. Causes of uveitis in children without juvenile idiopathic arthritis. Clin Ophthalmol Auckl NZ. 2015;9:1121\u20138.","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"596_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1034\/j.1600-0420.2000.078001084.x","volume":"78","author":"T P\u00e4iv\u00f6nsalo-Hietanen","year":"2000","unstructured":"P\u00e4iv\u00f6nsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000;78:84\u20138.","journal-title":"Acta Ophthalmol Scand"},{"key":"596_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/bjo.87.7.879","volume":"87","author":"J de Boer","year":"2003","unstructured":"de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879\u201384.","journal-title":"Br J Ophthalmol"},{"key":"596_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"596_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273940801899822","volume":"16","author":"J Deschenes","year":"2008","unstructured":"Deschenes J, Murray PI, Rao NA, Nussenblatt RB, International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16:1\u20132.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR10","first-page":"711","volume":"90","author":"LE Harman","year":"2014","unstructured":"Harman LE, Margo CE, Roetzheim RG. Uveitis: the collaborative diagnostic evaluation. Am Fam Physician. 2014;90:711\u20136.","journal-title":"Am Fam Physician"},{"key":"596_CR11","first-page":"259","volume":"6","author":"I Tugal-Tutkun","year":"2011","unstructured":"Tugal-Tutkun I. Pediatric uveitis. J Ophthalmic Vis Res. 2011;6:259\u201369.","journal-title":"J Ophthalmic Vis Res"},{"issue":"1544\u201351","key":"596_CR12","first-page":"1551.e1","volume":"116","author":"JA Smith","year":"2009","unstructured":"Smith JA, Mackensen F, Sen HN, Leigh JF, Watkins AS, Pyatetsky D, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116(1544\u201351):1551.e1.","journal-title":"Ophthalmology"},{"key":"596_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/0974-620X.122267","volume":"6","author":"PD Majumder","year":"2013","unstructured":"Majumder PD, Biswas J. Pediatric uveitis: an update. Oman J Ophthalmol. 2013;6:140\u201350.","journal-title":"Oman J Ophthalmol."},{"key":"596_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jfo.2011.02.019","volume":"35","author":"A Chebil","year":"2012","unstructured":"Chebil A, Chaabani L, Kort F, Ben Youssef N, Turki F, El Matri L. Epidemiologic study of pediatric uveitis: a series of 49 cases. J Fr Ophtalmol. 2012;35:30\u20134.","journal-title":"J Fr Ophtalmol"},{"key":"596_CR15","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.53738\/REVMED.2020.16.712.2059","volume":"16","author":"M Nissen","year":"2020","unstructured":"Nissen M, Guex-Crosier Y. Prise en charge des uv\u00e9ites non infectieuses li\u00e9es \u00e0 une maladie syst\u00e9mique: guide pour les praticiens. Rev M\u00e9dicale Suisse. 2020;16:2059\u201373.","journal-title":"Rev M\u00e9dicale Suisse."},{"key":"596_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.survophthal.2021.06.006","volume":"67","author":"A Maleki","year":"2022","unstructured":"Maleki A, Anesi SD, Look-Why S, Manhapra A, Foster CS. Pediatric uveitis: a comprehensive review. Surv Ophthalmol. 2022;67:510\u201329.","journal-title":"Surv Ophthalmol"},{"key":"596_CR17","doi-asserted-by":"publisher","first-page":"874711","DOI":"10.3389\/fped.2022.874711","volume":"10","author":"A Shivpuri","year":"2022","unstructured":"Shivpuri A, Turtsevich I, Solebo AL, Compeyrot-Lacassagne S. Pediatric uveitis: role of the pediatrician. Front Pediatr. 2022;10:874711.","journal-title":"Front Pediatr"},{"key":"596_CR18","first-page":"1","volume":"2023","author":"A Maleki","year":"2023","unstructured":"Maleki A, Patel PD, Foster CS. Juvenile idiopathic arthritis and its associated uveitis. Expert Rev Clin Immunol. 2023;2023:1\u201313.","journal-title":"Expert Rev Clin Immunol"},{"key":"596_CR19","first-page":"160","volume":"19","author":"C Malagon","year":"1992","unstructured":"Malagon C, Van Kerckhove C, Giannini EH, Taylor J, Lovell DJ, Levinson JE, et al. The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients. J Rheumatol. 1992;19:160\u20133.","journal-title":"J Rheumatol"},{"key":"596_CR20","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.autrev.2017.10.007","volume":"16","author":"A De Silvestri","year":"2017","unstructured":"De Silvestri A, Capittini C, Poddighe D, Marseglia GL, Mascaretti L, Bevilacqua E, et al. HLA-DRB1 alleles and juvenile idiopathic arthritis: diagnostic clues emerging from a meta-analysis. Autoimmun Rev. 2017;16:1230\u20136.","journal-title":"Autoimmun Rev"},{"key":"596_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/apt.15485","volume":"50","author":"JJ Ashton","year":"2019","unstructured":"Ashton JJ, Latham K, Beattie RM, Ennis S. Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease. Aliment Pharmacol Ther. 2019;50:885\u2013900.","journal-title":"Aliment Pharmacol Ther"},{"key":"596_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s13023-020-01620-4","volume":"16","author":"I Kone-Paut","year":"2021","unstructured":"Kone-Paut I, Barete S, Bodaghi B, Deiva K, Desbois A-C, Galeotti C, et al. French recommendations for the management of Beh\u00e7et\u2019s disease. Orphanet J Rare Dis. 2021;16:352.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl. 132","key":"596_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.55563\/clinexprheumatol\/pt60bc","volume":"39","author":"MA Turk","year":"2021","unstructured":"Turk MA, Hayworth JL, Nevskaya T, Pope JE. Ocular manifestations of Beh\u00e7et\u2019s disease in children and adults: a systematic review and meta-analysis. Clin Exp Rheumatol. 2021;39(Suppl. 132):94\u2013101.","journal-title":"Clin Exp Rheumatol"},{"key":"596_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bjo.2007.137141","volume":"93","author":"GK Sungur","year":"2009","unstructured":"Sungur GK, Hazirolan D, Yalvac I, Ozer PA, Yuksel D, Vural ET, et al. Clinical and demographic evaluation of Beh\u00e7et disease among different paediatric age groups. Br J Ophthalmol. 2009;93:83\u20137.","journal-title":"Br J Ophthalmol"},{"key":"596_CR25","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/art.24642","volume":"61","author":"M de Menthon","year":"2009","unstructured":"de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51\/B5 and the risk of Beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61:1287\u201396.","journal-title":"Arthritis Rheum"},{"key":"596_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1076\/ocii.6.3.155.4041","volume":"6","author":"SR Rathinam","year":"1998","unstructured":"Rathinam SR, Vijayalakshmi P, Namperumalsamy P, Nozik RA, Cunningham ET. Vogt-Koyanagi-Harada syndrome in children. Ocul Immunol Inflamm. 1998;6:155\u201361.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/bjo.78.3.223","volume":"78","author":"Y Shindo","year":"1994","unstructured":"Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada\u2019s disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol. 1994;78:223\u20136.","journal-title":"Br J Ophthalmol"},{"key":"596_CR28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0002-9394(14)74731-2","volume":"113","author":"XY Zhang","year":"1992","unstructured":"Zhang XY, Wang XM, Hu TS. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1992;113:567\u201372.","journal-title":"Am J Ophthalmol"},{"key":"596_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/jfmpc.jfmpc_787_19","volume":"9","author":"YB Patil","year":"2020","unstructured":"Patil YB, Garg R, Rajguru JP, Sirsalmath M, Bevinakatti VA, Kumar M, et al. Vogt-Koyanagi-Harada (VKH) syndrome: a new perspective for healthcare professionals. J Fam Med Prim Care. 2020;9:31\u20135.","journal-title":"J Fam Med Prim Care."},{"key":"596_CR30","doi-asserted-by":"publisher","first-page":"107853","DOI":"10.1016\/j.exer.2019.107853","volume":"190","author":"S Hou","year":"2020","unstructured":"Hou S, Li N, Liao X, Kijlstra A, Yang P. Uveitis genetics. Exp Eye Res. 2020;190:107853.","journal-title":"Exp Eye Res"},{"key":"596_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1034\/j.1600-0420.1998.760619.x","volume":"76","author":"KF Tabbara","year":"1998","unstructured":"Tabbara KF, Chavis PS, Freeman WR. Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand. 1998;76:723\u20136.","journal-title":"Acta Ophthalmol Scand"},{"key":"596_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10792-007-9062-9","volume":"27","author":"AS Al-Kharashi","year":"2007","unstructured":"Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D, Abu El-Asrar AM. Prognostic factors in Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27:201\u201310.","journal-title":"Int Ophthalmol"},{"key":"596_CR33","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archopht.118.10.1386","volume":"118","author":"H Dollfus","year":"2000","unstructured":"Dollfus H, H\u00e4fner R, Hofmann HM, Russo RAG, Denda L, Gonzales LD, et al. Chronic infantile neurological cutaneous and articular\/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol. 2000;118:1386\u201392.","journal-title":"Arch Ophthalmol"},{"key":"596_CR34","first-page":"53","volume":"29","author":"N Nathan","year":"2019","unstructured":"Nathan N, Sileo C, Calender A, Pacheco Y, Rosental P-A, Cavalin C, et al. Paediatric sarcoidosis. Paediatr Respir Rev. 2019;29:53\u20139.","journal-title":"Paediatr Respir Rev"},{"key":"596_CR35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/MCP.0000000000000814","volume":"27","author":"CM Sergi","year":"2021","unstructured":"Sergi CM. Pediatric sarcoidosis with diagnostic and therapeutical insights. Curr Opin Pulm Med. 2021;27:472\u20137.","journal-title":"Curr Opin Pulm Med"},{"key":"596_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1055\/s-0040-1710536","volume":"41","author":"P S\u00e8ve","year":"2020","unstructured":"S\u00e8ve P, Jamilloux Y, Tilikete C, Gerfaud-Valentin M, Kodjikian L, El Jammal T. Ocular sarcoidosis. Semin Respir Crit Care Med. 2020;41:673\u201388.","journal-title":"Semin Respir Crit Care Med."},{"key":"596_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajo.2018.09.013","volume":"198","author":"SP Ma","year":"2019","unstructured":"Ma SP, Rogers SL, Hall AJ, Hodgson L, Brennan J, Stawell RJ, et al. Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis. Am J Ophthalmol. 2019;198:30\u20136.","journal-title":"Am J Ophthalmol"},{"key":"596_CR38","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00417-019-04415-x","volume":"257","author":"C Coulon","year":"2019","unstructured":"Coulon C, Kodjikian L, Rochepeau C, Perard L, Jardel S, Burillon C, et al. Ethnicity and association with ocular, systemic manifestations and prognosis in 194 patients with sarcoid uveitis. Graefes Arch Clin Exp Ophthalmol. 2019;257:2495\u2013503.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"596_CR39","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/bjophthalmol-2018-313212","volume":"103","author":"F Groen-Hakan","year":"2019","unstructured":"Groen-Hakan F, Eurelings L, Rothova A, van Laar J. Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis. Br J Ophthalmol. 2019;103:1296\u2013300.","journal-title":"Br J Ophthalmol"},{"key":"596_CR40","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/bjophthalmol-2015-307455","volume":"100","author":"NP Jones","year":"2016","unstructured":"Jones NP, Tsierkezou L, Patton N. Lymphopenia as a predictor of sarcoidosis in patients with uveitis. Br J Ophthalmol. 2016;100:1393\u20136.","journal-title":"Br J Ophthalmol"},{"key":"596_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/bjophthalmol-2016-309767","volume":"101","author":"C Rochepeau","year":"2017","unstructured":"Rochepeau C, Jamilloux Y, Kerever S, Febvay C, Perard L, Broussolle C, et al. Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis. Br J Ophthalmol. 2017;101:856\u201361.","journal-title":"Br J Ophthalmol"},{"key":"596_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajo.2018.07.010","volume":"194","author":"RL Niederer","year":"2018","unstructured":"Niederer RL, Al-Janabi A, Lightman SL, Tomkins-Netzer O. Serum angiotensin-converting enzyme has a high negative predictive value in the investigation for systemic sarcoidosis. Am J Ophthalmol. 2018;194:82\u20137.","journal-title":"Am J Ophthalmol"},{"key":"596_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.autrev.2017.10.018","volume":"17","author":"P Grumet","year":"2018","unstructured":"Grumet P, Kodjikian L, de Parisot A, Errera M-H, Sedira N, Heron E, et al. Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (uveitis: clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis). Autoimmun Rev. 2018;17:331\u201343.","journal-title":"Autoimmun Rev"},{"key":"596_CR44","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10067-015-2870-9","volume":"35","author":"A Gedalia","year":"2016","unstructured":"Gedalia A, Khan TA, Shetty AK, Dimitriades VR, Espinoza LR. Childhood sarcoidosis: Louisiana experience. Clin Rheumatol. 2016;35:1879\u201384.","journal-title":"Clin Rheumatol"},{"issue":"93","key":"596_CR45","first-page":"30","volume":"2004","author":"AL Hoffmann","year":"1992","unstructured":"Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979\u20131994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr Oslo Nor. 1992;2004(93):30\u20136.","journal-title":"Acta Paediatr Oslo Nor"},{"key":"596_CR46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/thoraxjnl-2015-206825","volume":"70","author":"N Nathan","year":"2015","unstructured":"Nathan N, Marcelo P, Houdouin V, Epaud R, de Blic J, Valeyre D, et al. Lung sarcoidosis in children: update on disease expression and management. Thorax. 2015;70:537\u201342.","journal-title":"Thorax"},{"key":"596_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.prrv.2005.03.007","volume":"6","author":"B Fauroux","year":"2005","unstructured":"Fauroux B, Cl\u00e9ment A. Paediatric sarcoidosis. Paediatr Respir Rev. 2005;6:128\u201333.","journal-title":"Paediatr Respir Rev"},{"key":"596_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ppul.1950160109","volume":"16","author":"K Chadelat","year":"1993","unstructured":"Chadelat K, Baculard A, Grimfeld A, Tournier G, Boule M, Boccon-Gibod L, et al. Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment. Pediatr Pulmonol. 1993;16:41\u20137.","journal-title":"Pediatr Pulmonol"},{"key":"596_CR49","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0022-3476(85)80394-2","volume":"107","author":"EB Blau","year":"1985","unstructured":"Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689\u201393.","journal-title":"J Pediatr"},{"key":"596_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1546-0096-12-33","volume":"12","author":"CH Wouters","year":"2014","unstructured":"Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12:33.","journal-title":"Pediatr Rheumatol Online J"},{"key":"596_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng720","volume":"29","author":"C Miceli-Richard","year":"2001","unstructured":"Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, H\u00e4fner R, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19\u201320.","journal-title":"Nat Genet"},{"key":"596_CR52","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","volume":"54","author":"CD Ros\u00e9","year":"2015","unstructured":"Ros\u00e9 CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatol Oxf Engl. 2015;54:1008\u201316.","journal-title":"Rheumatol Oxf Engl."},{"key":"596_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neurol.2019.02.002","volume":"176","author":"K Deiva","year":"2020","unstructured":"Deiva K. Pediatric onset multiple sclerosis. Rev Neurol (Paris). 2020;176:30\u20136.","journal-title":"Rev Neurol (Paris)."},{"key":"596_CR54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5603\/PJNNS.a2020.0069","volume":"54","author":"W Brola","year":"2020","unstructured":"Brola W, Steinborn B. Pediatric multiple sclerosis\u2014current status of epidemiology, diagnosis and treatment. Neurol Neurochir Pol. 2020;54:508\u201317.","journal-title":"Neurol Neurochir Pol"},{"key":"596_CR55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0887-8994(95)00023-9","volume":"12","author":"MI Steinlin","year":"1995","unstructured":"Steinlin MI, Blaser SI, MacGregor DL, Raymond BJ. Eye problems in children with multiple sclerosis. Pediatr Neurol. 1995;12:207\u201312.","journal-title":"Pediatr Neurol"},{"key":"596_CR56","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/1120672120904667","volume":"31","author":"AF AlBloushi","year":"2021","unstructured":"AlBloushi AF, Dheyab AM, Al-Swaina NF, Al-Obailan M, Daif A-K, Abu El-Asrar AM. Clinical findings and outcomes of uveitis associated with multiple sclerosis. Eur J Ophthalmol. 2021;31:482\u201390.","journal-title":"Eur J Ophthalmol"},{"key":"596_CR57","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/aos.14697","volume":"99","author":"P Casselman","year":"2021","unstructured":"Casselman P, Cassiman C, Casteels I, Schauwvlieghe P-P. Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol (Copenh). 2021;99:592\u2013603.","journal-title":"Acta Ophthalmol (Copenh)."},{"key":"596_CR58","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.ajkd.2017.11.013","volume":"72","author":"DM Clive","year":"2018","unstructured":"Clive DM, Vanguri VK. The syndrome of tubulointerstitial nephritis with uveitis (TINU). Am J Kidney Dis. 2018;72:118\u201328.","journal-title":"Am J Kidney Dis"},{"key":"596_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12348-021-00236-4","volume":"11","author":"AH Nguyen","year":"2021","unstructured":"Nguyen AH, Mekonnen B, Kim E, Acharya NR. Clinical outcomes of pediatric macular edema associated with non-infectious uveitis. J Ophthalmic Inflamm Infect. 2021;11:8.","journal-title":"J Ophthalmic Inflamm Infect."},{"key":"596_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001196","volume":"6","author":"M Turk","year":"2020","unstructured":"Turk M, Hayworth J, Nevskaya T, Pope J. The frequency of uveitis in patients with adult versus childhood spondyloarthritis. RMD Open. 2020;6: e001196.","journal-title":"RMD Open"},{"key":"596_CR61","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.23871","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res. 2019;71:703\u201316.","journal-title":"Arthritis Care Res"},{"key":"596_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12969-018-0238-9","volume":"16","author":"M Goirand","year":"2018","unstructured":"Goirand M, Breton S, Chevallier F, Duong N-P, Uettwiller F, Melki I, et al. Clinical features of children with enthesitis-related juvenile idiopathic arthritis\/juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre. Pediatr Rheumatol Online J. 2018;16:21.","journal-title":"Pediatr Rheumatol Online J"},{"key":"596_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12969-020-00463-4","volume":"18","author":"A Marino","year":"2020","unstructured":"Marino A, Weiss PF, Brandon TG, Lerman MA. Juvenile spondyloarthritis: focus on uveitis. Pediatr Rheumatol Online J. 2020;18:70.","journal-title":"Pediatr Rheumatol Online J"},{"key":"596_CR64","doi-asserted-by":"publisher","first-page":"e000366","DOI":"10.1136\/rmdopen-2016-000366","volume":"3","author":"A Wei\u00df","year":"2017","unstructured":"Wei\u00df A, Minden K, Listing J, Foeldvari I, Sieper J, Rudwaleit M. Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC. RMD Open. 2017;3:e000366.","journal-title":"RMD Open"},{"key":"596_CR65","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5114\/reum.2015.53133","volume":"53","author":"Z \u017buber","year":"2015","unstructured":"\u017buber Z, Turowska-Heydel D, Sobczyk M, Chudek J. Prevalence of HLA-B27 antigen in patients with juvenile idiopathic arthritis. Reumatologia. 2015;53:125\u201330.","journal-title":"Reumatologia"},{"key":"596_CR66","first-page":"192","volume":"7","author":"NS-W Chan","year":"2018","unstructured":"Chan NS-W, Choi J, Cheung CMG. Pediatric uveitis. Asia Pac J Ophthalmol Phila. 2018;7:192\u20139.","journal-title":"Asia Pac J Ophthalmol Phila."},{"key":"596_CR67","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-0034-1368272","volume":"231","author":"Y Guex-Crosier","year":"2014","unstructured":"Guex-Crosier Y. Uveitis masquerade syndrome and orbital lymphoma: two challenging diagnosis. Klin Monatsbl Augenheilkd. 2014;231:303.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"596_CR68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/cge.14286","volume":"103","author":"C Fardeau","year":"2023","unstructured":"Fardeau C, Alafaleq M, Dhaenens C-M, Dollfus H, Kon\u00e9-Paut I, Grunewald O, et al. ROSAH syndrome mimicking chronic uveitis. Clin Genet. 2023;103:453\u20138.","journal-title":"Clin Genet"},{"key":"596_CR69","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1055\/s-2007-963274","volume":"224","author":"A Sch\u00fcler","year":"2007","unstructured":"Sch\u00fcler A, Coupland SE, Krause L, Bornfeld N. Malignant and non-malignant uveitis-masquerade syndromes in childhood. Klin Monatsbl Augenheilkd. 2007;224:477\u201382.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"596_CR70","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1111\/aos.14535","volume":"99","author":"M Siiskonen","year":"2021","unstructured":"Siiskonen M, Hirn I, Pes\u00e4l\u00e4 R, Hautala T, Ohtonen P, Hautala N. Prevalence, incidence and epidemiology of childhood uveitis. Acta Ophthalmol (Copenh). 2021;99:e160\u20133.","journal-title":"Acta Ophthalmol (Copenh)."},{"key":"596_CR71","first-page":"342","volume":"19","author":"JO Bishop","year":"1975","unstructured":"Bishop JO, Madson EC. Retinoblastoma: review of the current status. Surv Ophthalmol. 1975;19:342\u201366.","journal-title":"Surv Ophthalmol"},{"key":"596_CR72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3928\/0191-3913-20040101-06","volume":"41","author":"R Balasubramanya","year":"2004","unstructured":"Balasubramanya R, Pushker N, Bajaj MS, Ghose S, Kashyap S, Rani A. Atypical presentations of retinoblastoma. J Pediatr Ophthalmol Strabismus. 2004;41:18\u201324.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"596_CR73","unstructured":"Haute Aut. Sant\u00e9. Uv\u00e9ites chroniques non infectieuses de l\u2019enfant et de l\u2019adulte. 2023. https:\/\/www.has-sante.fr\/jcms\/p_3187246\/fr\/uveites-chroniques-non-infectieuses-de-l-enfant-et-de-l-adulte. Accessed 12 Feb 2023."},{"key":"596_CR74","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/acr.24963","volume":"75","author":"I Foeldvari","year":"2023","unstructured":"Foeldvari I, Maccora I, Petrushkin H, Rahman N, Anton J, de Boer J, et al. New and updated recommendations for the treatment of juvenile idiopathic arthritis-associated uveitis and idiopathic chronic anterior uveitis. Arthritis Care Res. 2023;75:975\u201382.","journal-title":"Arthritis Care Res"},{"key":"596_CR75","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ophtha.2020.01.036","volume":"127","author":"JE Thorne","year":"2020","unstructured":"Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2020;127:S21\u20136.","journal-title":"Ophthalmology"},{"key":"596_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semarthrit.2018.11.004","volume":"49","author":"A Heiligenhaus","year":"2019","unstructured":"Heiligenhaus A, Minden K, Tappeiner C, Baus H, Bertram B, Deuter C, et al. Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Semin Arthritis Rheum. 2019;49:43\u201355.","journal-title":"Semin Arthritis Rheum"},{"key":"596_CR77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12969-016-0069-5","volume":"14","author":"LA Henderson","year":"2016","unstructured":"Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS, et al. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatr Rheumatol Online J. 2016;14:9.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"23","key":"596_CR78","first-page":"00001","volume":"S0039\u20136257","author":"I Leal","year":"2023","unstructured":"Leal I, Steeples LR, Wong SW, Giuffre C, Pockar S, Sharma V, et al. Update on the systemic management of non-infectious uveitis in children and adolescents. Surv Ophthalmol. 2023;S0039\u20136257(23):00001\u20132.","journal-title":"Surv Ophthalmol"},{"key":"596_CR79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/17469899.2019.1663731","volume":"14","author":"L Kim","year":"2019","unstructured":"Kim L, Li A, Angeles-Han S, Yeh S, Shantha J. Update on the management of uveitis in children: an overview for the clinician. Expert Rev Ophthalmol. 2019;14:211\u20138.","journal-title":"Expert Rev Ophthalmol."},{"key":"596_CR80","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12969-018-0255-8","volume":"16","author":"G Ferrara","year":"2018","unstructured":"Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, Pappagallo G, et al. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatr Rheumatol Online J. 2018;16:46.","journal-title":"Pediatr Rheumatol Online J"},{"key":"596_CR81","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/ceo.13856","volume":"49","author":"JR Smith","year":"2021","unstructured":"Smith JR, Matthews JM, Conrad D, Hall AJ, Niederer RL, Singh-Grewal D, et al. Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis. Clin Experiment Ophthalmol. 2021;49:38\u201345.","journal-title":"Clin Experiment Ophthalmol"},{"key":"596_CR82","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.autrev.2010.05.017","volume":"9","author":"G Simonini","year":"2010","unstructured":"Simonini G, Cantarini L, Bresci C, Lorusso M, Galeazzi M, Cimaz R. Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev. 2010;9:674\u201383.","journal-title":"Autoimmun Rev"},{"key":"596_CR83","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1080\/09273948.2018.1529800","volume":"27","author":"WG Wieringa","year":"2019","unstructured":"Wieringa WG, Armbrust W, Legger GE, Los LI. Efficacy of high-dose methotrexate in pediatric non-infectious uveitis. Ocul Immunol Inflamm. 2019;27:1305\u201313.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR84","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","volume":"52","author":"G Simonini","year":"2013","unstructured":"Simonini G, Paudyal P, Jones GT, Cimaz R, Macfarlane GJ. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatol Oxf Engl. 2013;52:825\u201331.","journal-title":"Rheumatol Oxf Engl."},{"key":"596_CR85","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","volume":"151","author":"V Kalinina Ayuso","year":"2011","unstructured":"Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol. 2011;151:217\u201322.","journal-title":"Am J Ophthalmol"},{"key":"596_CR86","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","volume":"35","author":"R Bou","year":"2015","unstructured":"Bou R, Ad\u00e1n A, Borr\u00e1s F, Bravo B, Calvo I, De Inocencio J, et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int. 2015;35:777\u201385.","journal-title":"Rheumatol Int"},{"key":"596_CR87","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3899\/jrheum.130594","volume":"41","author":"JA Little","year":"2014","unstructured":"Little JA, Sen ES, Strike H, Hinchcliffe A, Guly CM, Lee RWJ, et al. The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhood. J Rheumatol. 2014;41:136\u20139.","journal-title":"J Rheumatol"},{"key":"596_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40674-017-0057-z","volume":"3","author":"AB Sood","year":"2017","unstructured":"Sood AB, Angeles-Han ST. An update on treatment of pediatric chronic non-infectious uveitis. Curr Treat Options Rheumatol. 2017;3:1\u201316.","journal-title":"Curr Treat Options Rheumatol."},{"key":"596_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/13543784.2012.636350","volume":"21","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Simonini G, Frediani B, Pagnini I, Galeazzi M, Cimaz R. Treatment strategies for childhood noninfectious chronic uveitis: an update. Expert Opin Investig Drugs. 2012;21:1\u20136.","journal-title":"Expert Opin Investig Drugs"},{"key":"596_CR90","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/eye.2008.174","volume":"23","author":"C Tappeiner","year":"2009","unstructured":"Tappeiner C, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye. 2009;23:1192\u20138.","journal-title":"Eye"},{"key":"596_CR91","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1056\/NEJM199206183262502","volume":"326","author":"G Feutren","year":"1992","unstructured":"Feutren G, Mihatsch MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med. 1992;326:1654\u201360.","journal-title":"N Engl J Med"},{"key":"596_CR92","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","volume":"149","author":"LB Vazquez-Cobian","year":"2006","unstructured":"Vazquez-Cobian LB, Flynn T, Lehman TJA. Adalimumab therapy for childhood uveitis. J Pediatr. 2006;149:572\u20135.","journal-title":"J Pediatr"},{"key":"596_CR93","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","volume":"77","author":"P Quartier","year":"2018","unstructured":"Quartier P, Baptiste A, Despert V, Allain-Launay E, Kon\u00e9-Paut I, Belot A, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis. 2018;77:1003\u201311.","journal-title":"Ann Rheum Dis"},{"key":"596_CR94","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376:1637\u201346.","journal-title":"N Engl J Med"},{"key":"596_CR95","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0002-9394(03)00225-3","volume":"135","author":"A Chia","year":"2003","unstructured":"Chia A, Lee V, Graham EM, Edelsten C. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;135:757\u201362.","journal-title":"Am J Ophthalmol"},{"key":"596_CR96","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/rheumatology\/ket260","volume":"53","author":"M Jani","year":"2014","unstructured":"Jani M, Barton A, Warren RB, Griffiths CEM, Chinoy H. The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases. Rheumatol (Oxf). 2014;53:213\u201322.","journal-title":"Rheumatol (Oxf)"},{"key":"596_CR97","doi-asserted-by":"publisher","first-page":"e001047","DOI":"10.1136\/rmdopen-2019-001047","volume":"6","author":"E Ducourau","year":"2020","unstructured":"Ducourau E, Rispens T, Samain M, Dernis E, Le Guilchard F, Andras L, et al. Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial. RMD Open. 2020;6:e001047.","journal-title":"RMD Open"},{"key":"596_CR98","doi-asserted-by":"publisher","unstructured":"Yang S, Huang Z, Hu Y, Zhang J, Liu X, Li H, et al. The efficacy of adalimumab as an initial treatment in patients with Beh\u00e7et\u2019s retinal vasculitis. Front Pharmacol.; 12. 2021. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fphar.2021.609148. Accessed 9 Aug 2023.","DOI":"10.3389\/fphar.2021.609148"},{"key":"596_CR99","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s40123-023-00712-1","volume":"12","author":"A Vitale","year":"2023","unstructured":"Vitale A, Casa FD, Guerriero S, Ragab G, Mauro A, Caggiano V, et al. Efficacy and safety of adalimumab in pediatric non-infectious non-anterior uveitis: real-life experience from the International AIDA Network Uveitis Registry. Ophthalmol Ther. 2023;12:1957\u201371.","journal-title":"Ophthalmol Ther"},{"key":"596_CR100","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1442-9071.2005.01062.x","volume":"33","author":"JC Richards","year":"2005","unstructured":"Richards JC, Tay-Kearney M-L, Murray K, Manners P. Infliximab for juvenile idiopathic arthritis-associated uveitis. Clin Exp Ophthalmol. 2005;33:461\u20138.","journal-title":"Clin Exp Ophthalmol"},{"key":"596_CR101","doi-asserted-by":"publisher","first-page":"765380","DOI":"10.5402\/2012\/765380","volume":"2012","author":"S Sukumaran","year":"2012","unstructured":"Sukumaran S, Marzan K, Shaham B, Reiff A. High dose infliximab in the treatment of refractory uveitis: does dose matter? ISRN Rheumatol. 2012;2012:765380.","journal-title":"ISRN Rheumatol."},{"key":"596_CR102","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000055677","volume":"33","author":"MS Lacomba","year":"2001","unstructured":"Lacomba MS, Mart\u00edn CM, Galera JMG, Vidal MAG, Est\u00e9vez EC, Chamond RR, et al. Aqueous humor and serum tumor necrosis factor-\u03b1 in clinical uveitis. Ophthalmic Res. 2001;33:251\u20135.","journal-title":"Ophthalmic Res"},{"key":"596_CR103","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s40744-021-00296-x","volume":"8","author":"Y Li","year":"2021","unstructured":"Li Y, Mao X, Tang X, Mao H. Efficacy and safety of anti-TNF\u03b1 therapy for uveitis associated with juvenile idiopathic arthritis: a systematic review and meta-Analysis. Rheumatol Ther. 2021;8:711\u201327.","journal-title":"Rheumatol Ther."},{"key":"596_CR104","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12969-021-00630-1","volume":"19","author":"S Lanz","year":"2021","unstructured":"Lanz S, Seidel G, Skrabl-Baumgartner A. Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to adalimumab. Pediatr Rheumatol Online J. 2021;19:132.","journal-title":"Pediatr Rheumatol Online J"},{"key":"596_CR105","first-page":"680","volume":"37","author":"GM Tosi","year":"2019","unstructured":"Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, et al. Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. Clin Exp Rheumatol. 2019;37:680\u20133.","journal-title":"Clin Exp Rheumatol"},{"key":"596_CR106","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41927-018-0010-2","volume":"2","author":"AV Ramanan","year":"2018","unstructured":"Ramanan AV, Dick AD, Jones AP, Guly C, Hardwick B, Hickey H, et al. A phase II trial protocol of tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial). BMC Rheumatol. 2018;2:4.","journal-title":"BMC Rheumatol"},{"key":"596_CR107","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09273948.2020.1817501","volume":"29","author":"A Maleki","year":"2021","unstructured":"Maleki A, Manhapra A, Asgari S, Chang PY, Foster CS, Anesi SD. Tocilizumab employment in the treatment of resistant juvenile idiopathic arthritis associated uveitis. Ocul Immunol Inflamm. 2021;29:14\u201320.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR108","first-page":"434","volume":"10","author":"C Iannone","year":"2023","unstructured":"Iannone C, Marelli L, Costi S, Pellico MR, La Franca L, Caporali R, et al. Tocilizumab in juvenile idiopathic arthritis associated uveitis, a narrative review. Child Basel Switz. 2023;10:434.","journal-title":"Child Basel Switz."},{"key":"596_CR109","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/S2665-9913(20)30008-4","volume":"2","author":"AV Ramanan","year":"2020","unstructured":"Ramanan AV, Dick AD, Guly C, McKay A, Jones AP, Hardwick B, et al. Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. Lancet Rheumatol. 2020;2:e135\u201341.","journal-title":"Lancet Rheumatol."},{"key":"596_CR110","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/09273948.2020.1712431","volume":"29","author":"RAW Wennink","year":"2021","unstructured":"Wennink RAW, Ayuso VK, de Vries LA, Vastert SJ, de Boer JH. Tocilizumab as an effective treatment option in children with refractory intermediate and panuveitis. Ocul Immunol Inflamm. 2021;29:21\u20135.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR111","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajo.2022.06.024","volume":"244","author":"V Miraldi Utz","year":"2022","unstructured":"Miraldi Utz V, Angeles-Han ST, Mwase N, Cassedy A, Hennard T, Lovell DJ, et al. Alternative biologic therapy in children failing conventional TNF\u03b1 inhibitors for refractory, noninfectious, chronic anterior uveitis. Am J Ophthalmol. 2022;244:183\u201395.","journal-title":"Am J Ophthalmol"},{"key":"596_CR112","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/09273948.2019.1589526","volume":"28","author":"L De Simone","year":"2020","unstructured":"De Simone L, Sangiovanni A, Aldigeri R, Mastrofilippo V, Bolletta E, Invernizzi A, et al. Interferon alpha-2a treatment for post-uveitic refractory macular edema. Ocul Immunol Inflamm. 2020;28:322\u20138.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR113","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/BOR.0000000000000911","volume":"35","author":"I Tugal-Tutkun","year":"2023","unstructured":"Tugal-Tutkun I. Uveitis in Beh\u00e7et disease: an update. Curr Opin Rheumatol. 2023;35:17\u201324.","journal-title":"Curr Opin Rheumatol"},{"key":"596_CR114","doi-asserted-by":"publisher","first-page":"699903","DOI":"10.3389\/fphar.2021.699903","volume":"12","author":"Y Qian","year":"2021","unstructured":"Qian Y, Qu Y, Gao F, Pei M, Liang A, Xiao J, et al. Comparison of the safety and efficacy of interferon alpha-2a and cyclosporine-A when combined with glucocorticoid in the treatment of refractory Beh\u00e7et\u2019s uveitis: a randomized controlled prospective study. Front Pharmacol. 2021;12:699903.","journal-title":"Front Pharmacol"},{"key":"596_CR115","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/09273948.2020.1815797","volume":"30","author":"L De Simone","year":"2022","unstructured":"De Simone L, Invernizzi A, Aldigeri R, Mastrofilippo V, Marvisi C, Gozzi F, et al. Effectiveness of infliximab and interferon alpha-2a for the treatment of Beh\u00e7et\u2019s uveitis: customizing therapy according to the clinical features. Ocul Immunol Inflamm. 2022;30:506\u201314.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR116","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11926-017-0670-8","volume":"19","author":"E Sag","year":"2017","unstructured":"Sag E, Bilginer Y, Ozen S. Autoinflammatory diseases with periodic fevers. Curr Rheumatol Rep. 2017;19:41.","journal-title":"Curr Rheumatol Rep"},{"key":"596_CR117","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S, et al. Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol. 2017;36:191\u20137.","journal-title":"Clin Rheumatol"},{"key":"596_CR118","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/1744666X.2023.2207823","volume":"19","author":"I Maccora","year":"2023","unstructured":"Maccora I, Land P, Miraldi Utz V, Angeles-Han ST. Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis. Expert Rev Clin Immunol. 2023;19:689\u201392.","journal-title":"Expert Rev Clin Immunol"},{"key":"596_CR119","doi-asserted-by":"publisher","first-page":"2324400","DOI":"10.1155\/2021\/2324400","volume":"2021","author":"J Wen","year":"2021","unstructured":"Wen J, Hu H, Chen M, Yang H, Zhao Y, Liu Y. Role of janus kinase (JAK) inhibitor in autoimmune ocular inflammation: a systematic review. J Immunol Res. 2021;2021:2324400.","journal-title":"J Immunol Res"},{"key":"596_CR120","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s13063-021-05651-5","volume":"22","author":"AV Ramanan","year":"2021","unstructured":"Ramanan AV, Guly CM, Keller SY, Schlichting DE, de Bono S, Liao R, et al. Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT). Trials. 2021;22:689.","journal-title":"Trials"},{"key":"596_CR121","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1080\/09273948.2022.2069128","volume":"31","author":"K Baquet-Walscheid","year":"2023","unstructured":"Baquet-Walscheid K, Heinz C, Rath T, Scheel M, Heiligenhaus A. Beneficial effect of upadacitinib in an adult patient with juvenile idiopathic arthritis-associated uveitis after unsatisfactory response to tofacitinib: a case report. Ocul Immunol Inflamm. 2023;31:1079\u201380.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR122","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1080\/09273948.2019.1605453","volume":"27","author":"P Bauermann","year":"2019","unstructured":"Bauermann P, Heiligenhaus A, Heinz C. Effect of Janus kinase inhibitor treatment on anterior uveitis and associated macular edema in an adult patient with juvenile idiopathic arthritis. Ocul Immunol Inflamm. 2019;27:1232\u20134.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR123","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10067-019-04875-w","volume":"39","author":"E Miserocchi","year":"2020","unstructured":"Miserocchi E, Giuffr\u00e8 C, Cornalba M, Pontikaki I, Cimaz R. JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis. Clin Rheumatol. 2020;39:847\u201351.","journal-title":"Clin Rheumatol"},{"key":"596_CR124","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jcrs.2008.12.014","volume":"35","author":"K Qui\u00f1ones","year":"2009","unstructured":"Qui\u00f1ones K, Cervantes-Casta\u00f1eda RA, Hynes AY, Daoud YJ, Foster CS. Outcomes of cataract surgery in children with chronic uveitis. J Cataract Refract Surg. 2009;35:725\u201331.","journal-title":"J Cataract Refract Surg"},{"key":"596_CR125","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12348-022-00313-2","volume":"12","author":"CLLI van Meerwijk","year":"2022","unstructured":"van Meerwijk CLLI, Jansonius NM, Los LI. Uveitic glaucoma in children: a systematic review on surgical outcomes. J Ophthalmic Inflamm Infect. 2022;12:35.","journal-title":"J Ophthalmic Inflamm Infect."},{"key":"596_CR126","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/bjophthalmol-2019-314875","volume":"104","author":"CSY Cheung","year":"2020","unstructured":"Cheung CSY, Mireskandari K, Ali A, Silverman E, Tehrani N. Earlier use of systemic immunosuppression is associated with fewer ophthalmic surgeries in paediatric non-infectious uveitis. Br J Ophthalmol. 2020;104:938\u201342.","journal-title":"Br J Ophthalmol"},{"key":"596_CR127","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/art.39621","volume":"68","author":"AM Haasnoot","year":"2016","unstructured":"Haasnoot AM, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W, Imhof SM, et al. Ocular fluid analysis in children reveals interleukin-29\/interferon-\u03bb1 as a biomarker for juvenile idiopathic arthritis-associated uveitis. Arthritis Rheumatol. 2016;68:1769\u201379.","journal-title":"Arthritis Rheumatol"},{"key":"596_CR128","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1167\/iovs.12-10865","volume":"54","author":"V Kalinina Ayuso","year":"2013","unstructured":"Kalinina Ayuso V, de Boer JH, Byers HL, Coulton GR, Dekkers J, de Visser L, et al. Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis. Invest Ophthalmol Vis Sci. 2013;54:3709\u201320.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"596_CR129","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1080\/09273948.2020.1758731","volume":"29","author":"ST Angeles-Han","year":"2021","unstructured":"Angeles-Han ST, Utz VM, Thornton S, Schulert G, Rodriguez-Smith J, Kauffman A, et al. S100 proteins, cytokines, and chemokines as tear biomarkers in children with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2021;29:1616\u201320.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR130","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12348-018-0156-5","volume":"8","author":"ST Angeles-Han","year":"2018","unstructured":"Angeles-Han ST, Yeh S, Patel P, Duong D, Jenkins K, Rouster-Stevens KA, et al. Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study. J Ophthalmic Inflamm Infect. 2018;8:17.","journal-title":"J Ophthalmic Inflamm Infect."},{"key":"596_CR131","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/art.42329","volume":"75","author":"JW van Straalen","year":"2023","unstructured":"van Straalen JW, Kearsley-Fleet L, Klotsche J, de Roock S, Minden K, Heiligenhaus A, et al. Development and external validation of a model predicting new-onset chronic uveitis at different disease durations in juvenile idiopathic arthritis. Arthritis Rheumatol. 2023;75:318\u201327.","journal-title":"Arthritis Rheumatol"},{"key":"596_CR132","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1186\/s13063-020-04796-z","volume":"21","author":"NR Acharya","year":"2020","unstructured":"Acharya NR, Ebert CD, Kelly NK, Porco TC, Ramanan AV, Arnold BF, et al. Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial. Trials. 2020;21:887.","journal-title":"Trials"},{"key":"596_CR133","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/a-1354-6452","volume":"238","author":"I Papasavvas","year":"2021","unstructured":"Papasavvas I, Gehrig B, Herbort CP. Clinical course and treatment paradigms for JIA-related uveitis and pars planitis uveitis using precise ocular investigational methods. Klin Monatsbl Augenheilkd. 2021;238:458\u201368.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"596_CR134","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/acr.22627","volume":"67","author":"ST Angeles-Han","year":"2015","unstructured":"Angeles-Han ST, Yeh S, McCracken C, Jenkins K, Stryker D, Myoung E, et al. Using the effects of youngsters\u2019 eyesight on quality of life questionnaire to measure visual outcomes in children with uveitis. Arthritis Care Res. 2015;67:1513\u201320.","journal-title":"Arthritis Care Res"},{"key":"596_CR135","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/acr.24551","volume":"74","author":"J McDonald","year":"2022","unstructured":"McDonald J, Cassedy A, Altaye M, Andringa J, Cooper AM, Drews-Botsch C, et al. Comprehensive assessment of quality of life, functioning, and mental health in children with juvenile idiopathic arthritis and noninfectious uveitis. Arthritis Care Res. 2022;74:1311\u201320.","journal-title":"Arthritis Care Res"},{"key":"596_CR136","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.ophtha.2004.06.014","volume":"111","author":"KD Rosenberg","year":"2004","unstructured":"Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299\u2013306.","journal-title":"Ophthalmology"},{"key":"596_CR137","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/09273948.2017.1420202","volume":"27","author":"M Ferrara","year":"2019","unstructured":"Ferrara M, Eggenschwiler L, Stephenson A, Montieth A, Nakhoul N, Ara\u00f9jo-Miranda R, et al. The challenge of pediatric uveitis: tertiary referral center experience in the United States. Ocul Immunol Inflamm. 2019;27:410\u20137.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR138","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/BOR.0000000000000316","volume":"28","author":"ST Angeles-Han","year":"2016","unstructured":"Angeles-Han ST, Rabinovich CE. Uveitis in children. Curr Opin Rheumatol. 2016;28:544\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"596_CR139","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/bjophthalmol-2018-312958","volume":"103","author":"J Choi","year":"2019","unstructured":"Choi J, Hawley DP, Ashworth J, Edelsten C, Bossuyt ASAM. An update on the modern management of paediatric uveitis. Br J Ophthalmol. 2019;103:1685\u20139.","journal-title":"Br J Ophthalmol"},{"key":"596_CR140","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/children8080646","volume":"8","author":"E Carlsson","year":"2021","unstructured":"Carlsson E, Beresford MW, Ramanan AV, Dick AD, Hedrich CM. Juvenile idiopathic arthritis associated uveitis. Children. 2021;8:646.","journal-title":"Children"},{"key":"596_CR141","doi-asserted-by":"publisher","first-page":"627192","DOI":"10.3389\/fmed.2021.627192","volume":"8","author":"M Yildiz","year":"2021","unstructured":"Yildiz M, Haslak F, Adrovic A, Sahin S, Koker O, Barut K, et al. Pediatric Beh\u00e7et\u2019s disease. Front Med. 2021;8:627192.","journal-title":"Front Med"},{"key":"596_CR142","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/ndt\/gfab030","volume":"37","author":"A Regusci","year":"2022","unstructured":"Regusci A, Lava SAG, Milani GP, Bianchetti MG, Simonetti GD, Vanoni F. Tubulointerstitial nephritis and uveitis syndrome: a systematic review. Nephrol Dial Transplant. 2022;37:876\u201386.","journal-title":"Nephrol Dial Transplant"},{"key":"596_CR143","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1212\/WNL.0000000000002881","volume":"87","author":"RQ Hintzen","year":"2016","unstructured":"Hintzen RQ, Dale RC, Neuteboom RF, Mar S, Banwell B. Pediatric acquired CNS demyelinating syndromes: features associated with multiple sclerosis. Neurology. 2016;87:S67-73.","journal-title":"Neurology"},{"key":"596_CR144","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/08820538.2021.1948067","volume":"37","author":"H Kaza","year":"2022","unstructured":"Kaza H, Tyagi M, Agarwal K, Behera S, Pappuru RR, Mohan S, et al. Vogt Koyanagi Harada disease in paediatric age group: clinical characteristics, remission, recurrences and complications in Asian Indian population. Semin Ophthalmol. 2022;37:187\u201392.","journal-title":"Semin Ophthalmol."},{"key":"596_CR145","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaophthalmol.2015.2249","volume":"133","author":"K Gallagher","year":"2015","unstructured":"Gallagher K, Viswanathan A, Okhravi N. Association of systemic lupus erythematosus with uveitis. JAMA Ophthalmol. 2015;133:1190\u20133.","journal-title":"JAMA Ophthalmol."},{"key":"596_CR146","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S2468-1253(21)00297-1","volume":"7","author":"L Guillo","year":"2022","unstructured":"Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, et al. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol. 2022;7:254\u201361.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"596_CR147","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/112067210701700509","volume":"17","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Mingels A, Heinz C, Ganser G. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol. 2007;17:743\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"596_CR148","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1546-0096-11-16","volume":"11","author":"G Simonini","year":"2013","unstructured":"Simonini G, Taddio A, Cattalini M, Caputo R, de Libero C, Parentin F, et al. Superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: adalimumab as starting anti-TNF-\u03b1 therapy in childhood chronic uveitis. Pediatr Rheumatol Online J. 2013;11:16.","journal-title":"Pediatr Rheumatol Online J"},{"key":"596_CR149","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3899\/jrheum.120583","volume":"40","author":"ME Zannin","year":"2013","unstructured":"Zannin ME, Birolo C, Gerloni VM, Miserocchi E, Pontikaki I, Paroli MP, et al. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. J Rheumatol. 2013;40:74\u20139.","journal-title":"J Rheumatol"},{"key":"596_CR150","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3109\/09273948.2013.844265","volume":"22","author":"E Miserocchi","year":"2014","unstructured":"Miserocchi E, Modorati G, Pontikaki I, Meroni PL, Gerloni V. Long-term treatment with golimumab for severe uveitis. Ocul Immunol Inflamm. 2014;22:90\u20135.","journal-title":"Ocul Immunol Inflamm"},{"key":"596_CR151","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0161-6420(99)90011-8","volume":"106","author":"S Dev","year":"1999","unstructured":"Dev S, McCallum RM, Jaffe GJ. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology. 1999;106:111\u20138.","journal-title":"Ophthalmology"},{"key":"596_CR152","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","volume":"47","author":"Y Jamilloux","year":"2017","unstructured":"Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, P\u00e9rard L, et al. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients. Semin Arthritis Rheum. 2017;47:288\u201394.","journal-title":"Semin Arthritis Rheum"},{"key":"596_CR153","doi-asserted-by":"publisher","unstructured":"Alpsoy E, Leccese P, Emmi G, Ohno S. Treatment of Beh\u00e7et\u2019s disease: an algorithmic multidisciplinary approach. Front Med. 2021;8. 2023. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fmed.2021.624795. Accessed 11 Mar 2023.","DOI":"10.3389\/fmed.2021.624795"},{"key":"596_CR154","first-page":"808","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, et al. 2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome. Ann Rheum Dis. 2018;77:808\u201318.","journal-title":"Ann Rheum Dis"},{"key":"596_CR155","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/acr.20308","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Wechsler B, Terrada C, Hajage D, Le Thi HD, Resche-Rigon M, et al. Azathioprine in severe uveitis of Beh\u00e7et\u2019s disease. Arthritis Care Res. 2010;62:1733\u20138.","journal-title":"Arthritis Care Res"},{"key":"596_CR156","first-page":"1107","volume":"77","author":"T Constantin","year":"2018","unstructured":"Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018;77:1107\u201317.","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-023-00596-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-023-00596-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-023-00596-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T15:16:47Z","timestamp":1704467807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-023-00596-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s40272-023-00596-5","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"14 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Ai Tien Nguyen, Isabelle Kon\u00e9-Paut, and Perrine Dusser have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"ATN performed the literature search and data analysis and drafted the manuscript. IK-P and PD critically revised the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}